English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Pharma & Biotech BioTech (Sci&Research)
Insumate(R)--Patented Peptide Sequence mcIRBP-19: a Boon for Diabetics Says Greenyn Biotechnology
Sep 28, 2020 16:00 HKT
Agilex Biolabs Develops World's Most Accurate Cannabinoid Assay
Sep 23, 2020 12:00 HKT
Avance Clinical Announces Expanded eClinical Solutions for Biotech Clinical Trials at BioPharm America
Sep 22, 2020 07:50 HKT
Impact BioMedical Demonstrates 10-Fold Reduction in Viral Population of COVID-19 in Surface Disinfectant Efficacy Testing of its 3F Antiviral Biofragrance
Sep 18, 2020 17:00 HKT
Dyadic Announces Collaboration with Jiangsu Hengrui Medicine for Biologic Drug Development
Sep 17, 2020 20:30 HKT
NanoViricides Nominates a Novel Candidate for Advancing Into Clinical Trials for Treatment of COVID-19
Sep 16, 2020 18:15 HKT
Aptorum Group to Hold Investor Webinar and Present at The Wall Street Investor Forum on September 10
Sep 08, 2020 15:52 HKT
Aptorum Group Joins the BEAM Alliance To Combat Antimicrobial Resistance
Sep 08, 2020 15:46 HKT
Regent Pacific enters longevity medicine business driven by leading AI technology through acquisition of Deep Longevity, Inc.
Sep 02, 2020 21:21 HKT
AI Startup Deep Longevity Launches with Series A Financing and New AI System to Tackle Aging-Related Diseases
Sep 02, 2020 08:55 HKT
Aptorum Group Announces Further Positive Data on ALS-4 against MRSA Wound Infection and MRSA Bacteraemia against Linezolid and Vancomycin Respectively in In Vivo Models
Sep 01, 2020 16:41 HKT
Aptorum Group Announces Further Positive Data on SACT-1 Against Neuroblastoma and Other Potential Tumor Types
Sep 01, 2020 16:32 HKT
Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2020
Sep 01, 2020 16:20 HKT
Hepalink Announces 2020 Interim Results
Aug 31, 2020 09:00 HKT
Junshi Biosciences Announces Financial Results for Six Months Ended June 30, 2020 and Provides Corporate Updates
Aug 31, 2020 08:20 HKT
Sino Biopharm Announces 2020 Interim Results
Aug 28, 2020 17:20 HKT
Novotech the Asia-Pacific CRO Leader - Awarded '2020 Frost & Sullivan Asia-Pacific CRO Company of the Year'
Aug 26, 2020 10:00 HKT
Sihuan Pharmaceutical Announces 2020 Interim Results
Aug 25, 2020 21:26 HKT
Ivermectin Triple Therapy Protocol for COVID-19 Released to Australian GPs for Infected Elderly and Frontline Workers
Aug 20, 2020 10:00 HKT
Bayer and Hua Medicine announce commercialization agreement and strategic partnership for investigational first-in-class novel diabetes treatment dorzagliatin in China
Aug 17, 2020 19:20 HKT
Next >>
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: